Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024)

Historic Other Non-Current Liabilities for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to $73000.0.

  • Artiva Biotherapeutics' Other Non-Current Liabilities fell 9970.92% to $73000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $73000.0, marking a year-over-year decrease of 9970.92%. This contributed to the annual value of $73000.0 for FY2024, which is 9970.92% down from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Other Non-Current Liabilities of $73000.0 as of Q4 2024, which was down 9970.92% from $73000.0 recorded in Q3 2024.
  • Over the past 5 years, Artiva Biotherapeutics' Other Non-Current Liabilities peaked at $27.7 million during Q2 2024, and registered a low of $73000.0 during Q3 2024.